Biotechnology firm Amgen (AMGN) Tuesday said it completed the acquisition of more than 99 percent of the shares of Turkey's Mustafa Nevzat Pharmaceuticals.
On April 25, Amgen agreed to buy 95.6 percent stake in Mustafa Nevzat Pharmaceuticals for $700 million in cash.
Mustafa Nevzat Pharmaceuticals supplies pharmaceuticals and injectable medicines in Turkey. It also has a fast growing export business. Amgen expects the acquisition to expand its presence in Turkey and the surrounding region, which are fast-growing, priority markets for the company.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.